Expansive Sosei lays out a $534M acquisition plan for the ambitious saRNA biotech MiNA
After swooping in to buy Heptares a couple of years ago in a $400 million deal, Sosei has put a new acquisition play in motion …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
